Women's Health Issues
Volume 20, Issue 1 , Pages 35-42 , January 2010

Impact of Patient Adherence and Test Performance on the Cost-Effectiveness of Cervical Cancer Screening in Developing Countries: The Case of Honduras

  • Rebecca B. Perkins, MD, MSc

      Affiliations

    • Department of Obstetrics and Gynecology, Boston University Medical Center, Boston, Massachusetts
    • Corresponding Author InformationCorrespondence to: Rebecca B. Perkins, MD, MSc, Department of Obstetrics and Gynecology, Boston University Medical Center, 85 E. Concord St. 6th Floor, Boston, MA 02118; Phone: 617-414-5993; Fax: 617-414-7303.
    • ,
  • Sarah M. Langrish, NP

      Affiliations

    • Emma Romero de Callejas Centro de Cancer, Tegucigalpa, Honduras
    • ,
  • Linda J. Stern, MPH

      Affiliations

    • Brigham and Women's Hospital- PROMESA project, Boston, Massachusetts
    • ,
  • James F. Burgess, PhD

      Affiliations

    • Department of Health Policy and Management, Boston University School of Public Health, Boston, Massachusetts
    • ,
  • Carol J. Simon, PhD

      Affiliations

    • Department of Health Policy and Management, Boston University School of Public Health, Boston, Massachusetts

Received 9 April 2009 ,Revised 4 September 2009 ,Accepted 9 September 2009.

References 

  1. Aareleid T, Pukkala E, Thomson H, Hakama M. Cervical cancer incidence and mortality trends in Finland and Estonia: A screened vs. an unscreened population. European Journal of Cancer. 1993;29A:745–749
  2. Agurto I, Sandoval J, De La Rosa M, Guardado ME. Improving cervical cancer prevention in a developing country. International Journal for Quality in Health Care. 2006;18:81–86
  3. Arrossi S, Sankaranarayanan R, Parkin DM. Incidence and mortality of cervical cancer in Latin America. Salud publica de Mexico. 2003;45(Suppl 3):S306–S314
  4. Christopherson WM. Lucy Wortham James Award. Cytologic detection and diagnosis of cancer. Its contributions and limitations. Cancer. 1983;51:1201–1208
  5. Claeys P, De Vuyst H, Gonzalez C, Garcia A, Bello RE, Temmerman M. Performance of the acetic acid test when used in field conditions as a screening test for cervical cancer. Tropical Medicine and International Health. 2003;8:704–709
  6. Denny L. The prevention of cervical cancer in developing countries. British Journal of Obstetrics and Gynaecology. 2005;112:1204–1212
  7. Denny L, Kuhn L, De Souza M, Pollack AE, Dupree W, Wright TC. Screen-and-treat approaches for cervical cancer prevention in low-resource settings: A randomized controlled trial. Journal of the American Medical Association. 2005;294:2173–2181
  8. Gaffikin L, Blumenthal PD, Emerson M, Limpaphayom K. Safety, acceptability, and feasibility of a single-visit approach to cervical-cancer prevention in rural Thailand: A demonstration project. Lancet. 2003;361:814–820
  9. Goldie SJ, Gaffikin L, Goldhaber-Fiebert JD, Gordillo-Tobar A, Levin C, Mahe C, et al. Cost-effectiveness of cervical-cancer screening in five developing countries. New England Journal of Medicine. 2005;353:2158–2168
  10. Goldie SJ, Kuhn L, Denny L, Pollack A, Wright TC. Policy analysis of cervical cancer screening strategies in low-resource settings: Clinical benefits and cost-effectiveness. Journal of the American Medical Association. 2001;285:3107–3115
  11. International Agency for Research on Cancer. (2009). [homepage on the Internet]. Available: http://www.iarc.fr/en/about/index.php. Accessed July 28.
  12. JHPIEGO. (2009). Regional single visit approach using VIA and cryotherapy clinical training course. Available: http://www.jhpiego.org/media/featarticles/ft20081218.htm. Accessed July 28, 2009.
  13. Jeronimo J, Morales O, Horna J, Pariona J, Manrique J, Rubinos J, et al. Visual inspection with acetic acid for cervical cancer screening outside of low-resource settings. Revista panamericana de salud publica. 2005;17:1–5
  14. Laara E, Day NE, Hakama M. Trends in mortality from cervical cancer in the Nordic countries: Association with organised screening programmes. Lancet. 1987;1:1247–1249
  15. Lazcano-Ponce EC, Moss S, Alonso de Ruiz P, Salmeron Castro J, Hernandez Avila M. Cervical cancer screening in developing countries: Why is it ineffective? The case of Mexico. Archives of Medical Research. 1999;30:240–250
  16. Legood R, Gray AM, Mahe C, Wolstenholme J, Jayant K, Nene BM, et al. Screening for cervical cancer in India: How much will it cost? A trial based analysis of the cost per case detected. International Journal of Cancer. 2005;117:981–987
  17. Mandelblatt JS, Lawrence WF, Gaffikin L, Limpahayom KK, Lumbiganon P, Warakamin S, et al. Costs and benefits of different strategies to screen for cervical cancer in less-developed countries. Journal of the National Cancer Institute. 2002;94:1469–1483
  18. Megevand E, Denny L, Dehaeck K, Soeters R, Bloch B. Acetic acid visualization of the cervix: An alternative to cytologic screening. Obstetrics and Gynecology. 1996;88:383–386
  19. Melnikow J, Nuovo J, Willan AR, Chan BK, Howell LP. Natural history of cervical squamous intraepithelial lesions: A meta-analysis. Obstetrics and Gynecology. 1998;92:727–735
  20. Nuovo J, Melnikow J, Willan AR, Chan BK. Treatment outcomes for squamous intraepithelial lesions. Internation Journal of Gynaecology and Obstetrics. 2000;68:25–33
  21. Ostor AG. Natural history of cervical intraepithelial neoplasia: a critical review. International Journal of Gynecologic Pathology. 1993;12:186–192
  22. Perkins RB, Langrish SM, Stern LJ, Figueroa J, Simon CJ. Comparison of visual inspection and Papanicolaou (PAP) smears for cervical cancer screening in Honduras: should PAP smears be abandoned?. Tropical Medicine and International Health. 2007;12:1018–1025
  23. Robles SC, White F, Peruga A. Trends in cervical cancer mortality in the Americas. Bulletin of the Pan American Health Organ. 1996;30:290–301
  24. Sankaranarayanan R, Basu P, Wesley RS, Mahe C, Keita N, Mbalawa CC, et al. Accuracy of visual screening for cervical neoplasia: Results from an IARC multicentre study in India and Africa. International Journal of Cancer. 2004;110:907–913
  25. Secretary of State of Honduras. (2004). Presidential report: Information by department and municipality (appendix 4; pp. 1–37). Honduran State Department, Tegucigalpa, Honduras.
  26. Suba EJ, Murphy SK, Donnelly AD, Furia LM, Huynh ML, Raab SS. Systems analysis of real-world obstacles to successful cervical cancer prevention in developing countries. American Journal of Public Health. 2006;96:480–487
  27. U.S. Department of Health And Human Services. Healthy people 2010. Available at Washington, DC: Author; 2000;http://www.healthypeople.gov/document/HTML/Volume1/03Cancer.htm
  28. University of Zimbabwe/JHPIEGO Cervical Cancer Project. Visual inspection with acetic acid for cervical-cancer screening: Test qualities in a primary-care setting. Lancet. 1999;353:869–873
  29. World Health Organization. (2009). Comprehensive cervical cancer control, a guide to essential practice. Available: http://www.who.int/reproductive-health/publications/cervical_cancer_gep/text.pdf. Accessed July 28, 2006.
  30. Wright TC, Massad LS, Dunton CJ, Spitzer M, Wilkinson EJ, Solomon D. 2006 consensus guidelines for the management of women with abnormal cervical cancer screening tests. American Journal of Obstetrics and Gynecology. 2007;197:346–355
  31. Wright TC. Cervical cancer screening using visualization techniques. Review. Journal of the National Cancer Institute Monographs. 2003;31:66–71

 Funding for the cervical cancer prevention project from which primary data was gathered was provided by the Alliance for Cervical Cancer Prevention Small Grants Program. Funding for research was provided by the Building Interdisciplinary Careers in Women's Health (BIRCWH) Scholar Program K12-HD43444.

PII: S1049-3867(09)00102-9

doi: 10.1016/j.whi.2009.09.001

Women's Health Issues
Volume 20, Issue 1 , Pages 35-42 , January 2010

Article Tools

* Image Usage & Resolution